# Giovanni Leo

> Giovanni Leo is a seed investor at Efficient Frontier Investing backing Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Efficient Frontier Investing](https://shizune.co/investors/profile/efficient-frontier-investing)
- Location: Geneva, Switzerland
- Total investments: 5
- Last investment: Sep 2023
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/giovanni-leo/8/529/b00
- X (Twitter): https://twitter.com/Innogest_VC
- Website: http://www.innogestcapital.com
- Facebook: https://www.facebook.com/innogestvc/

Giovanni Leo is a seed investor at Efficient Frontier Investing in Geneva focused on Health Care and Medical Device. Giovanni Leo is the Partner at Efficient Frontier Investing.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $4M–$5.1M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 80% |
| Medical Device | 3 | 60% |
| Medical | 2 | 40% |
| Navigation | 1 | 20% |
| Biotechnology | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series B | 2 | 40% |
| Series A | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 4 | 80% |
| Italy | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hylomorph | Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M | Series B | Sep 05, 2023 |  |
| EBAMed | EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients. | $15.7M | Series A | Jun 27, 2023 |  |
| Terapet | Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch. | $2.5M | Seed | Feb 17, 2023 |  |
| Medyria | Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland. | $4M | Series B | Jan 10, 2023 |  |
| CV Lab | CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs. |  | Seed | Sep 12, 2016 |  |

5 of 5 investments shown.

## Co-investors
- [StartAngels Network](https://shizune.co/investors/profile/startangels-network) — VC Fund, 2 deals together
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund, 2 deals together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together
- [Excellis](https://shizune.co/investors/profile/excellis) — VC Fund, 1 deal together
- [FONGIT](https://shizune.co/investors/profile/fongit) — VC Fund, 1 deal together
- [Innogest Capital](https://shizune.co/investors/profile/innogest-sgr) — VC Fund, 1 deal together

## About Efficient Frontier Investing

VC Fund · Geneva, Switzerland

Efficient Frontier Investing is an investment firm that specializes in both private and public investment. Efficient Frontier Investing was founded in 2018 and was headquartered in Geneva.

2 contacts available at Efficient Frontier Investing.

| Name | Title | Profile |
| --- | --- | --- |
| Caroline Cantele | Head of Funds Operations | https://shizune.co/investors/profile/caroline-cantele |
| Giovanni Leo | Partner | https://shizune.co/investors/profile/giovanni-leo |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors in Italy](https://shizune.co/investors/medical-device-angel-investors-italy)

## FAQ

### What does Giovanni Leo invest in?

Giovanni Leo invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Giovanni Leo's check size?

Giovanni Leo typically joins rounds of $4M–$5.1M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Giovanni Leo participates in.

### When did Giovanni Leo last invest?

The most recent investment recorded for Giovanni Leo closed in Sep 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co